3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
8
Recurrence
3
Neurofibrosarcoma
2
Lymphoma, Large B-Cell, Diffuse
2
Wilms Tumor
1
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Interventions
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Dexamethasone
2
Calcium Dobesilate
2
Biopsy
2
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
2
venetoclax
1
ixazomib
1
daratumumab
1
belantamab mafodotin
1
X-Rays
1
Stem Cell Transplantation
1
Phantoms, Imaging
1
Melphalan
1
Cyclophosphamide
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
selinexor
×
30 days
×
Clear all
No trials found.